A purified seahorse-derived peptide inhibited MMP, iNOS, and COX-2 inflammatory mediators through MAPK and NF-κB pathway suppression — a marine-derived anti-inflammatory peptide with arthritis potential.
Key findingA purified seahorse-derived peptide inhibited MMP, iNOS, and COX-2 inflammatory mediators through MAPK and NF-κB pathway suppression — a marine-derive
What the researchers found
A purified seahorse-derived peptide inhibited MMP, iNOS, and COX-2 inflammatory mediators through MAPK and NF-κB pathway suppression — a marine-derived anti-inflammatory peptide with arthritis potential.
Why it matters
Relevant for peptide research.
How the study worked
research study.
What this study cannot tell us
See abstract.
How to read the evidence
emerging evidence.
When this study was published
Published in 2010.
The bigger picture
Advances peptide research.
Questions still open
- Further research needed.
Common questions
What was studied?
What was found?
Read the original research
Purification of a peptide from seahorse, that inhibits TPA-induced MMP, iNOS and COX-2 expression through MAPK and NF-kappaB activation, and induces human osteoblastic and chondrocytic differentiation.
Chemico-biological interactions, 184(3), 413-22
Citation
Ryu, BoMi; Qian, Zhong-Ji; Kim, Se-Kwon. (2010). Purification of a peptide from seahorse, that inhibits TPA-induced MMP, iNOS and COX-2 expression through MAPK and NF-kappaB activation, and induces human osteoblastic and chondrocytic differentiation.. Chemico-biological interactions, 184(3), 413-22. https://doi.org/10.1016/j.cbi.2009.12.003